8th European Pharma Licensing Symposium

	EUROPHARM SMC & EPLS B2B MEETING
12pm - 12.30pm	Delegates Arrive & Registration
12.30pm - 2pm	Networking Buffet Lunch
2pm - 6pm	Organised B2B Partnering Sessions
6,30pm - 8.30pm	Welcome Drinks Reception

	8th EPLS
09.30am - 10.30am	Registration Royal Suite Foyer Area
	SESSION A - STRATEGIC ISSUES
10.30am - 11.15am	Value Convergence - Overview of Where Healthcare is Heading STEPHEN AHERNE, Director, Pharmaceutical Strategy & Valuations, PricewaterhouseCoopers
11.15am - 12pm	Healthcare Deals Overview PAUL VERDIN, Head of Custom Services, Evaluate
12pm - 12.45pm	Case Study - Sanofi Digital Strategy RACHEL SHA, Global Transactions Lead, Business Development & Licensing, Sanofi
12.45pm - 2pm	Lunch
	SESSION B - DEAL FINANCES & VALUATION
2pm - 2.40pm	Financial Perspectives: Where is the Deal Money Coming From? PAUL PAY, Chief Business Development Officer, Norgine
2.40pm - 3.20pm	How a PE Investor Can Help an Entrepreneur in the Healthcare Sector LOIC KUBITZA, Operating Partner, ArchiMed
3.20pm - 3.50pm	Break
	SESSION C - BIOSIMILARS / GENERICS
3.50pm - 4.30pm	Biosimilars Across Europe: Challenges and Trends ALAN SHEPPARD, Principal, Global Generics and Biosimilars, Thought Leadership, IMS Health
4.30pm - 5.10pm	Focus on Biosimilars/Generics Deal Aspects ULRICH OSSWALD, Head of Global BD&L Biopharmaceuticals, Sandoz
5.10pm- 5.50pm	Innovative Drug Repositioning and Repurposing DORIAN BEVEC, Chief Development Officer, Relief Therapeutics
5.50pm - 6.30pm	Strengthening Licensing Opportunities Through Patient Group Partnerships MARK KRUEGER, President, MK&A
7pm - 10.30pm	Networking Drinks Reception & Gala Dinner Théatre du Vaudeville

8.30am - 9am	Good Partnering Practices Update Swiss HLG
	SESSION D - PANEL DISCUSSION: EUROPEAN MARKET ACCESS
9am - 9.50am	Review of Current Market Access Issues Across Europe France - Philippe Rozo, Business Development Director, Laboratoires Bouchara Recordati Germany - ROBERT WELTE, Head of Market Access, GSK Pharma Germany Italy - LIVIO GARATTINI, Director, Centre for Health Economics (CESAV) UK - DAVID ALDERSON, Director, Cogentia
9.50am - 10.30am	Panel Discussion Chaired by ANDRÁS INCZE, Founder & CEO, Akceso Advisors
10.30am - 11am	Break
	SESSION E - PATIENT CENTRICITY / DIGITAL HEALTH
11am - 11.45am	The Growing Influence of Digital Technology on Healthcare - Where Medicine is Heading: Digital Health & Disease Interception TAHERA KAN, Director Partnership, EMEA New Business Development, Janssen
11.450am - 12.30pm	Case Study: Bayer Grants4Apps Project JESUS DEL VALLE ROSALES, Head of Bayer Grants4Apps, Bayer
12.30pm	Lunch & Close

Events